Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference
Modular Medical Announces Launch of Pivot Insulin Delivery System Across Five Key U.S. Markets Beginning October 2026
Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman
Modular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health Records
Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump
Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery
Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements
Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump
Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps
Modular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial Expansion
Modular Medical Launches New Website for Pivot Tubeless Insulin Patch Pump
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026
Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock
Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump
Modular Medical Announces 1-for-30 Reverse Stock Split
Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market
Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump
Modular Medical Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule
Modular Medical Announces Pricing of $4.68 Million Public Offering
Modular Medical Announces Proposed Public Offering
Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump
Modular Medical Submits Pivot Tubeless Insulin Patch Pump for FDA 510(k) Clearance
Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System
Modular Medical Announces Ongoing Progress to Obtain CE Mark
Modular Medical Appoints David Bosshard to Lead its International Expansion for the Pivot Insulin Delivery System
Modular Medical Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
Modular Medical Announces Completion of MODD1 Cartridge Production and Commencement of Pivot Conversion
Modular Medical Announces Next-Generation Pivot Insulin Pump at ADCES and Introduction of Level Ex Gamified Training Collaboration
Modular Medical Announces First Human Use of MODD1 Pump Delivering Insulin
Modular Medical Announces MODD1 Cartridge Line Validated for Human-Use Production
Modular Medical to Present Data from Study Examining Pump Delivery of a GLP-1R Agonist at the ADA 85th Scientific Sessions
Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of Directors
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "Making Diabetes Management Simpler: The New Era of Insulin Therapy" Featuring Modular Medical CEO - Wednesday, May 28, 2025
Modular Medical to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
Modular Medical Announces $12 Million Private Placement
Modular Medical Announces BSI Group as Trusted Body for CE Mark Clearance